Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001384612 | SCV001584179 | pathogenic | Wilson disease | 2020-09-13 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Glu396*) in the ATP7B gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has been observed in the homozygous state in individual(s) with Wilson's disease (PMID: 18483695). Loss-of-function variants in ATP7B are known to be pathogenic (PMID: 10441329, 16283883). For these reasons, this variant has been classified as Pathogenic. |
Genome- |
RCV001384612 | SCV001977380 | pathogenic | Wilson disease | 2021-08-10 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV001384612 | SCV004216365 | pathogenic | Wilson disease | 2023-08-08 | criteria provided, single submitter | clinical testing |